Public Citizen Accuses Pfizer of Building ‘Paxlovid Patent Wall,’ Pfizer Pushes Back Post author:PacConAdmin Post published:February 18, 2022 Post category:Drug Industry Daily The advocacy group Public Citizen is accusing Pfizer of building a “Paxlovid patent wall.” Source: Drug Industry Daily You Might Also Like Thyroid API Manufacturer Gets Warning Letter for Validation, Conformance Lapses May 20, 2022 FDA Under Pressure to Grant Swift EUA for Moderna’s Vaccine for Young Children April 28, 2022 FDA Cancer Lead Signals Distaste for Sintilimab’s China-Only Data Package February 7, 2022